Product Recalls in Maryland

Product recalls affecting Maryland — including food, drugs, consumer products, medical devices, and vehicles distributed to Maryland. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,899 recalls have been distributed to Maryland in the last 12 months.

52,535 total recalls
2,899 in last 12 months

Showing 761780 of 13,385 recalls

DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg Recalled by Akron Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg Recalled by Akron Pharma, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 12, 2024· Buy-Herbal

Recalled Item: Nhan Sam Tuyet Lien Truy Phong Hoan Recalled by Buy-Herbal Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found the products to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 12, 2024· GNMart LLC

Recalled Item: FORCE FOREVER 400mg Tablets Recalled by GNMart LLC Due to Marketed without...

The Issue: Marketed without an approved NDA/ANDA. FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 12, 2024· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Recalled by Ascend Laboratories, LLC Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 12, 2024· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Recalled by Ascend Laboratories, LLC Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 11, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: chlorproMAZINE Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 11, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: chlorproMAZINE Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· Regenerative Processing Plant, LLC

Recalled Item: LITE Regener-Eyes Recalled by Regenerative Processing Plant, LLC Due to Lack...

The Issue: Lack of Sterility Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2024· Regenerative Processing Plant, LLC

Recalled Item: PROFESSIONAL Regener-Eyes Recalled by Regenerative Processing Plant, LLC Due...

The Issue: Lack of Sterility Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Amerisource Health Services...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Amerisource Health...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Amerisource Health...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Amerisource Health Services LLC

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Amerisource Health Services...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 6, 2024· Aurobindo Pharma USA Inc

Recalled Item: Nebivolol Tablets Recalled by Aurobindo Pharma USA Inc Due to CGMP...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund